ProSomnus announced today that it raised $38 million through a strategic investment from Catalio Capital Management.
Nearly 30 million Americans struggle with obstructive sleep apnea, yet many avoid the standard treatment, CPAP. Some get frustrated with the mask, while ...
Everyday Health on MSN
CPAP vs. medication: Which obstructive sleep apnea (OSA) treatment is more effective?
Compare the efficacy, benefits, and drawbacks of CPAP therapy and tirzepatide (Zepbound), two of the best treatments for sleep apnea.
Save up to 59% on these holy grail devices that diminish fine lines, improve tone and texture, and create a more radiant complexion.
ResMed (RMD) is back in focus after reporting higher sales and net income for its second quarter and first half of fiscal 2026, alongside a fresh quarterly dividend declaration of $0.60 per share. See ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results